Lynne Elmore joined MUSC Hollings Cancer Center as the director of research development.
Suzanne Conzen, chief of the Hematology and Oncology Division at UT Southwestern Harold C. Simmons Comprehensive Cancer Center, appeared on the Cancer Luminaries podcast, a series launched by the UChicago Medicine Comprehensive Cancer Center to mark its 50th year as a National Cancer Institute-designated center.
After a year of lean appropriations, NCI is looking at what threatens to be a budgetary cataclysm—a potential 10-11% cut to the Labor-HHS spending bill in fiscal year 2025.
Oana Danciu, associate director for clinical research at the University of Illinois Cancer Center, was appointed by the Big Ten Cancer Research Consortium as chair of its steering committee.
While cutting-edge therapies grace headlines, the impact of breakthrough research remains limited due to patient access, affordability, and adherence.
Northwell Health and the START Center for Cancer Research announced plans to form a groundbreaking partnership.Â
The governing body of the Cancer Prevention and Research Institute of Texas approved $51.8 million in grants to advance the state’s fight against cancer. The grants are a mix of academic research recruitment grants and product development research projects.
Over the past three years, the American Cancer Society has recovered from the fundraising decline brought on by COVID-19 and has reversed the years-long fundraising slump in public support.
The American Association for Cancer Research has named its newest class of grant recipients.
Researchers from Fred Hutchinson Cancer Center, the American Cancer Society Cancer Action Network, and peer institutions released findings in the Journal of Clinical Oncology showing that when all types of cancer research studies are considered, at least one in five people with cancer, or 21.9%, participate in some form of clinical research.
